Attenuation of Experimental Atherosclerosis by Interleukin-19

OBJECTIVE: Interleukin-19 (IL-19) is putative Th2, anti-inflammatory interleukin. Its expression in, and potential role in atherogenesis is unknown. IL-19 is not detected in normal artery, and is expressed to a greater degree in plaque from symptomatic vs. asymptomatic patients, suggesting a compens...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Ellison, Stephen, Gabunia, Khatuna, Kelemen, Sheri E., England, Ross N., Scalia, Rosario, Richards, James M., Orr, Wayne, Traylor, James G., Rogers, Thomas, Cornwell, William, Berglund, Lisa M., Goncalves, Isabel, Gomez, Maria F., Autieri, Michael V.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3950941/
https://ncbi.nlm.nih.gov/pubmed/23950143
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/ATVBAHA.113.301521
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi